SA47 Clinical Effectiveness of Osimertinib in Non-Small Cell Lung Cancer Patients With EGFR Mutation Between Plasma and Tissue Re-Biopsy: A Systematic Review and Meta-Analysis of Real-World Evidence
Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.2441
https://www.valueinhealthjournal.com/article/S1098-3015(22)04646-0/fulltext
Title :
SA47 Clinical Effectiveness of Osimertinib in Non-Small Cell Lung Cancer Patients With EGFR Mutation Between Plasma and Tissue Re-Biopsy: A Systematic Review and Meta-Analysis of Real-World Evidence
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)04646-0&doi=10.1016/j.jval.2022.09.2441
First page :
Section Title :
Open access? :
No
Section Order :
12010